eugliptin
Phase 3- Indications
- Diabetes
Company intelligence / Profile preview
Chengdu Yuandong Bio-pharmaceutical Co., Ltd. ("Yuandong Bio") is an innovation-driven pharmaceutical platform company based in Chengdu, China. It focuses on the research & development, production, and integration of active pharmaceutical ingredients (APIs) and finished dosage forms. The company has a strong emphasis on internationalization and operates at commercial scale with ongoing investments into new facilities for expanded production capacity. There are no publicly disclosed clinical trial results or novel drug candidates attributed to this entity as of May 2025.
6 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Yuandong Bio-pharmaceutical Co., Ltd..